A multiplex molecular panel utilizing qPCR and NGS technology for detection of breast cancer-associated genetic markers and mutations. Supports diagnostic confirmation and prognostic assessment for breast cancer management.
Manufactured by
United Kingdom
YouSeq has developed the world's largest menu of qPCR and NGS tests. Empower your laboratory with over 1000 targets to build panels for PGx, RPP, UTI, STI, Wound, Fungal, Gastro, Oncology, Inherited disease testing and more.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Yaneng BIOscience (Shenzhen) Co.,Ltd.
China · 4 relevant products
BioChain (Beijing) Science & Technology. Inc.
China · 3 relevant products
Genes 2Me Private Ltd
India · 5 relevant products
Burning Rock Dx Co. Ltd.
China · 4 relevant products
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 3 relevant products
Bioscience (Tianjin) DiagnosticTechnology Co.,Ltd
China · 1 relevant product
Guangzhou LBP Medicine Science & Technology Co.,Ltd.
China · 2 relevant products
Rayto Life and Analytical Sciences Co., Ltd.
China · 1 relevant product
Biopsense Oy
Finland · 1 relevant product
Medicover Genetics Ltd
Cyprus · 2 relevant products
49 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →7 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 108 closest product alternatives
Yaneng BIOscience (Shenzhen) Co.,Ltd. · China
Nucleic acid detection kit for screening breast cancer-related genetic markers. Enables risk stratification for breast cancer predisposition assessment.
BioChain (Beijing) Science & Technology. Inc. · China
Next-generation sequencing-based multiplex cancer screening panel for simultaneous detection of multiple cancer types. This advanced molecular diagnostic test enables comprehensive cancer risk stratification from single blood samples. The product is in development as part of the company's precision oncology pipeline.
Genes 2Me Private Ltd · India
Genomic sequencing panel for cancer-related mutation and biomarker detection. Supports precision oncology treatment planning and selection.
Burning Rock Dx Co. Ltd. · China
Next-generation sequencing panel for comprehensive cancer genomic profiling. Identifies mutations, copy number variations, and other genetic alterations to guide personalized treatment strategies.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Precision medicine diagnostic test for cancer screening and early detection. Part of the comprehensive oncology testing portfolio covering multiple cancer types.
Bioscience (Tianjin) DiagnosticTechnology Co.,Ltd · China
Comprehensive multigene panel for hereditary disease identification and cancer risk assessment. Provides clinical-grade analysis with detailed genomic reporting.
Guangzhou LBP Medicine Science & Technology Co.,Ltd. · China
Comprehensive tumor profiling panel utilizing LBP, IHC, PCR, and FISH methods to characterize tumor biology. This integrated approach provides multi-level diagnostic information for precision oncology.
Rayto Life and Analytical Sciences Co., Ltd. · China
Multi-analyte immunoassay for cancer screening and monitoring biomarkers. Supports oncology patient management and follow-up.
Biopsense Oy · Finland
Blood test panel for detecting and characterizing genetic and epigenetic mutations in circulating tumor DNA. Helps determine cancer origin, measure tumor burden, and identify new mutations during targeted therapy treatment.
Medicover Genetics Ltd · Cyprus
Genetic testing for cancer predisposition and somatic cancer variants to identify individuals at risk or with diagnosed malignancies. Includes comprehensive sequencing with clinical validation and genetic counselling.
Fujirebio Diagnostics,Inc. · China
In vitro diagnostic test panel for detection of multiple tumor markers with simplified experimental workflow and reliable accuracy. The assay provides stable results suitable for cancer screening and monitoring.
Bioantibody Biotechnology Co., Ltd. · China
Quantitative immunoassay for cancer-related tumor markers. Supports cancer screening, diagnosis, and treatment monitoring.
96 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products